Search for: "NATIONAL LEGISLATIVE ASSOCIATION ON PRESCRIPTION DRUG PRICES"
Results 21 - 40
of 104
Sort by Relevance
|
Sort by Date
3 Dec 2020, 9:05 pm
The Canadian government, however, emphasized that the HHS rule would not be an effective approach to reduce drug prices, given the smaller size of the Canadian pharmaceutical industry relative to the U.S. prescription drug market. [read post]
16 Oct 2020, 9:07 pm
He asserts that an absence of a unified national approach to address drug prices has created a patchwork of state legislation. [read post]
17 Jun 2020, 6:30 am
Members of the claim management team and other interested stakeholders should take note of recent actions by the National Council of Insurance Legislators (NCOIL). [read post]
9 Jun 2020, 1:55 am
A potency- and weight-based tax defined by THC levels may be the best short-term solution for lawmakers assuming that THC is an appropriate proxy for the externalities associated with consuming marijuana. [read post]
30 Mar 2020, 2:42 pm
For instance, New York has five proposed bills that, taken together, target medical supplies price gouging and price gouging by manufacturers of prescription drugs, create a private right of action, define an unconscionably excessive price, and impose criminal penalties. [read post]
25 Mar 2020, 12:21 pm
The relevant crimes include price fixing, bid-rigging, and customer and territorial allocation, and are normally subject to a five-year statute of limitations. [read post]
16 Mar 2020, 12:43 pm
Employees taking voluntary or involuntary leave likely already are entitled to certain paid or unpaid leave and associated benefit, reinstatement and other rights under a hodgepodge of voluntarily established company policies and other federal, state and even local regulations. [read post]
2 Mar 2020, 11:04 am
Currently, insured plans covered by the MLR rule as well as the PBM arrangements of many self-insured, employer or union sponsored health plans, do not require PBMs to disclose, account for, or pass through to the health plan they are engaged by the prescription drug rebates and certain other amounts that PBMs receive and retain from prescription drug manufacturers that the PBM selects for inclusion on the health plan formulary. [read post]
2 Mar 2020, 7:29 am
Among other things, the Proposed Rule, if adopted as proposed, would: Repeal regulations relating to the Early Retiree Reinsurance Program; Require health plans in state insurance markets to count drug rebates and price concessions retained by pharmacy benefit managers (PBMs) as administrative expenses. [read post]
3 Feb 2020, 4:15 pm
Why exactly would senators vote to proceed on a matter of grave national security significance ill-informed when the evidence remains available to them? [read post]
10 Dec 2019, 4:02 pm
This faster rate of growth was driven by non-price factors, such as the use and mix of drugs consumed, which more than offset a decline of 1.0 percent in prices for retail prescription drugs. [read post]
5 Dec 2019, 9:05 pm
” To qualify, individuals must test negative for HIV, have a valid prescription, and lack prescription drug coverage. [read post]
23 Aug 2019, 3:00 am
More are considering legislation. [read post]
19 Aug 2019, 11:58 am
” In celebration of National Breastfeeding Month, the U.S. [read post]
19 Jul 2019, 3:00 am
How Pharma, Under Attack from All Sides, Keeps Winning in Washington STAT – Nicholas Forko and Lev Facher | Published: 7/16/2019 Even though Washington has stepped up its rhetorical attacks on the industry and focused its policymaking efforts on reining in high drug prices, the pharmaceutical industry’s time-honored lobbying and advocacy strategies have kept both lawmakers and the Trump administration from landing any of their prescription-drug… [read post]
16 Jul 2019, 2:01 pm
Stamer has been extensively involved in U.S. federal, state and local health care and other legislative and regulatory reform impacting these concerns throughout her career. [read post]
12 Jul 2019, 3:00 am
The Republican National Committee (RNC) is threatening to withhold support from party candidates who refuse to use WinRed, the GOP’s newly established online fundraising tool. [read post]
13 Jun 2019, 9:15 pm
The bill’s sponsor, Representative Michael McCaul (R-Texas), said the legislation would “foster collaboration between the public and private sector to ensure our nation can continue to adapt to the constant changes in the cyber landscape. [read post]
13 Jun 2019, 12:26 pm
Pursuant to European legislation, we have competent authorities, the European Medicines Agency (EMA) or national medicines evaluation board (MEB), seriously assessing the efficacy and safety of medicinal products before they enter the market. [read post]
11 Jun 2019, 5:41 am
Francer, the draft bill would promote patent thickets, stifle innovation, and undermine Congressional efforts to control prescription drug costs. [read post]
